Literature DB >> 28816025

Aromatic interactions at the ligand-protein interface: Implications for the development of docking scoring functions.

Michal Brylinski1,2.   

Abstract

The ability to design and fine-tune non-covalent interactions between organic ligands and proteins is indispensable to rational drug development. Aromatic stacking has long been recognized as one of the key constituents of ligand-protein interfaces. In this communication, we employ a two-parameter geometric model to conduct a large-scale statistical analysis of aromatic contacts in the experimental and computer-generated structures of ligand-protein complexes, considering various combinations of n class="Chemical">aromatic amino acid residues anpan>d liganpan>d rinpan>gs. The geometry of inpan>terfacial π-π stackinpan>g inpan> crystal structures accords with experimental anpan>d theoretical data collected for simple systems, such as the pan> class="Chemical">benzene dimer. Many contemporary ligand docking programs implicitly treat aromatic stacking with van der Waals and Coulombic potentials. Although this approach generally provides a sufficient specificity to model aromatic interactions, the geometry of π-π contacts in high-scoring docking conformations could still be improved. The comprehensive analysis of aromatic geometries at ligand-protein interfaces lies the foundation for the development of type-specific statistical potentials to more accurately describe aromatic interactions in molecular docking. A Perl script to detect and calculate the geometric parameters of aromatic interactions in ligand-protein complexes is available at https://github.com/michal-brylinski/earomatic. The dataset comprising experimental complex structures and computer-generated models is available at https://osf.io/rztha/.
© 2017 John Wiley & Sons A/S.

Entities:  

Keywords:  aromatic interactions; ligand binding; ligand docking; molecular docking; molecular modeling; non-covalent interactions; parallel stacking; perpendicular stacking; protein-ligand complexes; π-π interactions

Mesh:

Substances:

Year:  2017        PMID: 28816025      PMCID: PMC5818208          DOI: 10.1111/cbdd.13084

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  59 in total

Review 1.  Rediscovery of halogen bonds in protein-ligand complexes.

Authors:  P Zhou; F Tian; J Zou; Z Shang
Journal:  Mini Rev Med Chem       Date:  2010-04       Impact factor: 3.862

2.  GeauxDock: A novel approach for mixed-resolution ligand docking using a descriptor-based force field.

Authors:  Yun Ding; Ye Fang; Wei P Feinstein; Jagannathan Ramanujam; David M Koppelman; Juana Moreno; Michal Brylinski; Mark Jarrell
Journal:  J Comput Chem       Date:  2015-08-06       Impact factor: 3.376

3.  General and targeted statistical potentials for protein-ligand interactions.

Authors:  Wijnand T M Mooij; Marcel L Verdonk
Journal:  Proteins       Date:  2005-11-01

4.  Crystal structure of maize serine racemase with pyridoxal 5'-phosphate.

Authors:  Lingling Zou; Yang Song; Chengliang Wang; Jiaqi Sun; Leilei Wang; Beijiu Cheng; Jun Fan
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2016-02-16       Impact factor: 1.056

5.  Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set.

Authors:  Huiyong Sun; Youyong Li; Sheng Tian; Lei Xu; Tingjun Hou
Journal:  Phys Chem Chem Phys       Date:  2014-08-21       Impact factor: 3.676

Review 6.  Cation-pi bonding and amino-aromatic interactions in the biomolecular recognition of substituted ammonium ligands.

Authors:  N S Scrutton; A R Raine
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

7.  An aspartate and a water molecule mediate efficient acid-base catalysis in a tailored antibody pocket.

Authors:  Erik W Debler; Roger Müller; Donald Hilvert; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

8.  The role of stacking interactions in complexes of proteins with adenine and Guanine fragments of ligands.

Authors:  T V Pyrkov; D V Pyrkova; E D Balitskaya; R G Efremov
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

9.  DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Authors:  David S Wishart; Craig Knox; An Chi Guo; Savita Shrivastava; Murtaza Hassanali; Paul Stothard; Zhan Chang; Jennifer Woolsey
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets.

Authors:  Wei P Feinstein; Michal Brylinski
Journal:  J Cheminform       Date:  2015-05-15       Impact factor: 5.514

View more
  12 in total

1.  eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.

Authors:  Michal Brylinski; Misagh Naderi; Rajiv Gandhi Govindaraj; Jeffrey Lemoine
Journal:  J Mol Biol       Date:  2017-12-10       Impact factor: 5.469

2.  The discovery of penta-peptides inhibiting the activity of the formylglycine-generating enzyme and their potential antibacterial effects against Mycobacterium tuberculosis.

Authors:  Nicholas Asiimwe; Mohammad Faysal Al Mazid; Yong Taek Jeong; Juyong Lee; Jun-Seok Lee
Journal:  RSC Adv       Date:  2022-06-29       Impact factor: 4.036

Review 3.  How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms.

Authors:  Meredith Corley; Margaret C Burns; Gene W Yeo
Journal:  Mol Cell       Date:  2020-04-02       Impact factor: 17.970

4.  Synthesis and Evaluation of 4-Hydroxycoumarin Imines as Inhibitors of Class II Myosins.

Authors:  Jhonnathan Brawley; Emily Etter; Dante Heredia; Amarawan Intasiri; Kyle Nennecker; Joshua Smith; Brandon M Welcome; Richard K Brizendine; Thomas W Gould; Thomas W Bell; Christine Cremo
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

5.  Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis.

Authors:  Kerry Silva McPherson; Angela M Zaino; Radha C Dash; Alessandro A Rizzo; Yunfeng Li; Bing Hao; Irina Bezsonova; M Kyle Hadden; Dmitry M Korzhnev
Journal:  ChemMedChem       Date:  2021-01-28       Impact factor: 3.466

6.  Synthesis, antibacterial activity and molecular docking study of vanillin derived 1,4-disubstituted 1,2,3-triazoles as inhibitors of bacterial DNA synthesis.

Authors:  Mumtaz Hussain; Tahir Qadri; Zahid Hussain; Aamer Saeed; Pervaiz Ali Channar; Syeda Aaliya Shehzadi; Mubashir Hassan; Fayaz Ali Larik; Tarique Mahmood; Arif Malik
Journal:  Heliyon       Date:  2019-11-19

Review 7.  A Supramolecular Approach to Structure-Based Design with A Focus on Synthons Hierarchy in Ornithine-Derived Ligands: Review, Synthesis, Experimental and in Silico Studies.

Authors:  Joanna Bojarska; Milan Remko; Martin Breza; Izabela D Madura; Krzysztof Kaczmarek; Janusz Zabrocki; Wojciech M Wolf
Journal:  Molecules       Date:  2020-03-03       Impact factor: 4.411

8.  Molecular Mechanisms of Anti-Inflammatory Activities of the Extracts of Ocimum gratissimum and Thymus vulgaris.

Authors:  Ige Francis Olaoye; Babatunde Joseph Oso; Adepeju Aberuagba
Journal:  Avicenna J Med Biotechnol       Date:  2021 Oct-Dec

9.  Transcriptomic and Drug Discovery Analyses Reveal Natural Compounds Targeting the KDM4 Subfamily as Promising Adjuvant Treatments in Cancer.

Authors:  Aylin Del Moral-Morales; Marisol Salgado-Albarrán; Elizabeth Ortiz-Gutiérrez; Gerardo Pérez-Hernández; Ernesto Soto-Reyes
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

10.  Chemical Reactivity and Optical and Pharmacokinetics Studies of 14 Multikinase Inhibitors and Their Docking Interactions Toward ACK1 for Precision Oncology.

Authors:  Ruby Srivastava
Journal:  Front Chem       Date:  2022-04-14       Impact factor: 5.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.